What is the potential of daratumumab in combination therapy for myeloma?
Immunotherapy for multiple myeloma: current research avenues
Overview of a Phase II clinical trial of isatuximab
Overview of the SIRIUS clinical trial in the treatment of multiple myeloma
Recent drug approvals for the treatment of relapsed/refractory multiple myeloma